Updated just now · Live
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Established Pharmaceutical, Diagnostic, Nutritional, and Medical Devices segments, with brands like FreeStyle Libre and Ensure.
Abbott Laboratories operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ABT.
How to read insider trading filings
Johnson & Johnson
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ABT Stock Intelligence Report. [stoxpulse.com/stocks/abt]
Disclaimer: The information on this page about Abbott Laboratories (ABT) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Abbott Laboratories.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
Wall Street Refuses to Blink: 2 Healthcare Stocks ...
1h ago
Is the Options Market Predicting a Spike in Abbott...
3h ago
StoxPulse AI results for ABT: Pulse Score 53/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$167.20B
P/E Ratio
33.6
EPS
$1.02
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Established Pharmaceutical, Diagnostic, Nutritional, and Medical Devices segments, with brands like FreeStyle Libre and Ensure.
Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love
Is the Options Market Predicting a Spike in Abbott Laboratories Stock?
Abbott Laboratories Just Got Interesting: Dividend Yield Near 3% Signals Opportunity
Abbott Laboratories: Buy The Dip On This Dividend King
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom
Abbott’s CancerGuard Progress Adds New Dimension To Diagnostics Growth Story
EY on the current state of the medtech industry
Drug-Eluting Stents - Global Market Trends, Developments and Investment Opportunities 2026-2034